Eszopiclone and Ipratropium bromide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Eszopiclone (eszopiclone) and Ipratropium bromide (ipratropium bromide). Common drug interactions include injection site mass among females and bacteraemia among males.

The phase IV clinical study analyzes what interactions people have when they take Eszopiclone and Ipratropium bromide. It is created by eHealthMe based on reports of 34 people who take the same drugs from the FDA, and is updated regularly.

What is Eszopiclone?

Eszopiclone has active ingredients of eszopiclone. It is often used in insomnia. eHealthMe is studying from 4,258 Eszopiclone users. Check the latest studies of Eszopiclone.

What is Ipratropium bromide?

Ipratropium bromide has active ingredients of ipratropium bromide. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 17,965 Ipratropium bromide users. Check the latest studies of Ipratropium bromide.



On Jul, 05, 2026

34 people who take Eszopiclone and Ipratropium bromide together, and have interactions are studied.

Eszopiclone and Ipratropium bromide drug interactions.

What are the common drug interactions of Eszopiclone and Ipratropium Bromide, by gender? *:

female:

  1. Injection site mass
  2. Injection site pain
  3. Injection site swelling
  4. Injection site urticaria (rash of round, red welts on the skin at injection site)
  5. Lactic acidosis (low ph in body tissues)
  6. Muscle spasms (muscle contraction)
  7. Neoplasm malignant (cancer tumour)
  8. Neuralgia (pain in one or more nerves)
  9. Ocular discomfort (a generic expression when there is lack of ease in/about the eyes)
  10. Oxygen saturation decreased

male:

  1. Bacteraemia (presence of bacteria in the blood)
  2. Blood urea increased
  3. Decreased appetite
  4. Drug intolerance (drug sensitivity)
  5. White blood cell count increased
  6. Alopecia (absence of hair from areas of the body)
  7. Anaemia (lack of blood)
  8. Apnoea (suspension of external breathing)
  9. Chronic kidney disease
  10. Colitis ischaemic (due to infection of intestine impaired blood supply to colon)

What are the common drug interactions of Eszopiclone and Ipratropium Bromide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Dyspnoea (difficult or laboured respiration)
  2. Oxygen saturation decreased
  3. Respiratory tract infection
  4. Sinusitis (inflammation of sinus)
  5. Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)

40-49:

n/a

50-59:

  1. Blood urea increased
  2. C-reactive protein increased
  3. Confusional state
  4. Haemoglobin decreased
  5. Hypersomnia (excessive daytime sleepiness (eds))
  6. Hypoalbuminaemia (levels of albumin in blood serum are abnormally low)
  7. Memory impairment
  8. Neutrophil count increased (excess than normal number of neutrophil a type of blood cell)
  9. Poor quality sleep
  10. Weight increased

60+:

  1. Headache (pain in head)
  2. Infusion related reaction
  3. Arthralgia (joint pain)
  4. Back pain
  5. Body height decreased
  6. Cardiac failure congestive
  7. Chest discomfort
  8. Chest pain
  9. Costochondritis (chest wall pain)
  10. Cough

What are the existing conditions these people have? *

  1. Sleep Disorder: 6 people, 17.65%
  2. Febrile Neutropenia (fever with reduced white blood cells): 4 people, 11.76%
  3. Stress And Anxiety: 4 people, 11.76%
  4. Affective Disorder (mental disorder): 4 people, 11.76%
  5. Anaemia (lack of blood): 4 people, 11.76%
  6. Asthma: 4 people, 11.76%
  7. Blood Uric Acid Increased: 4 people, 11.76%
  8. Bone Disorder: 4 people, 11.76%
  9. Constipation: 4 people, 11.76%
  10. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 4 people, 11.76%

* Approximation only. Some reports may have incomplete information.

Do you take Eszopiclone and Ipratropium bromide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Eszopiclone and Ipratropium bromide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Eszopiclone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ipratropium bromide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Eszopiclone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ipratropium bromide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on eszopiclone and ipratropium bromide (the active ingredients of Eszopiclone and Ipratropium bromide, respectively), and Eszopiclone and Ipratropium bromide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: